Clinical Trial Update: Variable Interval Versus Set Interval Aflibercept for DME [Phase 4]

View source ↗

Summary

Phase 4 trial comparing variable interval vs set interval aflibercept for cystoid macular edema and diabetic macular edema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystoid Macular Edema
• Diabetic Macular Edema

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: California Retina Consultants | Conditions: Cystoid Macular Edema, Diabetic Macular Edema | Phase 4 | Status: COMPLETED